 Bradford Siegele
Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burkitt Lymphoma | 2 | 2022 | 60 | 0.910 |
Why?
| | Sarcoma | 2 | 2025 | 188 | 0.640 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2024 | 289 | 0.630 |
Why?
| | Leukemia, Hairy Cell | 1 | 2018 | 7 | 0.600 |
Why?
| | Pancytopenia | 1 | 2018 | 8 | 0.600 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2024 | 80 | 0.580 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2024 | 1692 | 0.460 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 215 | 0.460 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2016 | 96 | 0.450 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 506 | 0.400 |
Why?
| | Immunohistochemistry | 5 | 2022 | 1738 | 0.400 |
Why?
| | ErbB Receptors | 1 | 2016 | 614 | 0.390 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2022 | 683 | 0.390 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1276 | 0.360 |
Why?
| | Mutation | 3 | 2025 | 3958 | 0.350 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2024 | 630 | 0.330 |
Why?
| | Mouth Neoplasms | 2 | 2025 | 120 | 0.300 |
Why?
| | Head and Neck Neoplasms | 2 | 2018 | 606 | 0.290 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.290 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1483 | 0.250 |
Why?
| | Genetic Therapy | 1 | 2008 | 297 | 0.250 |
Why?
| | Neoplasm, Residual | 2 | 2024 | 133 | 0.250 |
Why?
| | Gene Rearrangement | 2 | 2024 | 150 | 0.240 |
Why?
| | Azacitidine | 2 | 2024 | 140 | 0.240 |
Why?
| | Neoplasm Metastasis | 1 | 2008 | 658 | 0.240 |
Why?
| | Papilloma | 1 | 2025 | 52 | 0.240 |
Why?
| | Erythroblasts | 1 | 2025 | 19 | 0.230 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2025 | 63 | 0.230 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 2 | 2024 | 227 | 0.230 |
Why?
| | Immunophenotyping | 2 | 2025 | 318 | 0.220 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 70 | 0.200 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2022 | 16 | 0.200 |
Why?
| | Sulfonamides | 2 | 2024 | 513 | 0.200 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2526 | 0.190 |
Why?
| | Salivary Gland Neoplasms | 1 | 2022 | 41 | 0.190 |
Why?
| | Gene Fusion | 1 | 2022 | 27 | 0.190 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 136 | 0.190 |
Why?
| | Translocation, Genetic | 2 | 2022 | 105 | 0.190 |
Why?
| | Lymphoproliferative Disorders | 1 | 2022 | 57 | 0.180 |
Why?
| | Papillomavirus Infections | 1 | 2025 | 325 | 0.180 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 98 | 0.170 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 123 | 0.170 |
Why?
| | Epistaxis | 1 | 2018 | 12 | 0.150 |
Why?
| | Organ Transplantation | 1 | 2022 | 250 | 0.150 |
Why?
| | Lymphadenopathy | 1 | 2018 | 10 | 0.150 |
Why?
| | Erythema | 1 | 2018 | 29 | 0.150 |
Why?
| | Child | 7 | 2025 | 21935 | 0.140 |
Why?
| | Forearm | 1 | 2018 | 119 | 0.140 |
Why?
| | Myelodysplastic Syndromes | 1 | 2019 | 135 | 0.140 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2018 | 69 | 0.140 |
Why?
| | Parotid Neoplasms | 1 | 2017 | 16 | 0.140 |
Why?
| | Parotid Gland | 1 | 2017 | 23 | 0.140 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 97 | 0.140 |
Why?
| | Humans | 18 | 2025 | 137585 | 0.130 |
Why?
| | Adolescent | 6 | 2025 | 21513 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2019 | 1236 | 0.130 |
Why?
| | Young Adult | 4 | 2025 | 13209 | 0.130 |
Why?
| | Cadherins | 1 | 2018 | 206 | 0.130 |
Why?
| | Neck | 1 | 2017 | 101 | 0.130 |
Why?
| | Cysts | 1 | 2017 | 113 | 0.130 |
Why?
| | Spleen | 1 | 2018 | 514 | 0.130 |
Why?
| | Lymphoma | 1 | 2017 | 208 | 0.120 |
Why?
| | Phosphoproteins | 1 | 2018 | 338 | 0.120 |
Why?
| | Teratoma | 1 | 2017 | 114 | 0.120 |
Why?
| | Codon | 1 | 2016 | 89 | 0.120 |
Why?
| | Male | 11 | 2025 | 67762 | 0.120 |
Why?
| | Aged, 80 and over | 4 | 2025 | 7635 | 0.120 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2016 | 98 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2018 | 430 | 0.120 |
Why?
| | Fatal Outcome | 1 | 2016 | 303 | 0.120 |
Why?
| | Amino Acid Substitution | 1 | 2016 | 307 | 0.110 |
Why?
| | DNA Mutational Analysis | 1 | 2016 | 399 | 0.110 |
Why?
| | Ultrasonography | 1 | 2018 | 759 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2019 | 622 | 0.110 |
Why?
| | Pain | 1 | 2018 | 756 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2024 | 10811 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1129 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1946 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2691 | 0.090 |
Why?
| | Female | 8 | 2025 | 73304 | 0.080 |
Why?
| | Prognosis | 3 | 2024 | 4030 | 0.070 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2008 | 7 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3566 | 0.070 |
Why?
| | Mice, Inbred C3H | 1 | 2008 | 269 | 0.070 |
Why?
| | Aged | 4 | 2025 | 23961 | 0.070 |
Why?
| | Neoplasms, Experimental | 1 | 2008 | 176 | 0.070 |
Why?
| | Genetic Vectors | 1 | 2008 | 319 | 0.060 |
Why?
| | Disease-Free Survival | 1 | 2008 | 686 | 0.060 |
Why?
| | Adult | 4 | 2025 | 37929 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2025 | 15657 | 0.060 |
Why?
| | Papillomaviridae | 1 | 2025 | 125 | 0.060 |
Why?
| | Child, Preschool | 3 | 2025 | 11074 | 0.060 |
Why?
| | Infant | 3 | 2025 | 9465 | 0.050 |
Why?
| | Antigens, CD20 | 1 | 2022 | 29 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2022 | 156 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 317 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2022 | 139 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2024 | 1062 | 0.040 |
Why?
| | Rituximab | 1 | 2022 | 176 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 33479 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5131 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 3412 | 0.040 |
Why?
| | Trans-Activators | 1 | 2022 | 398 | 0.040 |
Why?
| | Remission Induction | 1 | 2019 | 288 | 0.040 |
Why?
| | Hepatocyte Growth Factor | 1 | 2018 | 35 | 0.040 |
Why?
| | Biopsy, Fine-Needle | 1 | 2017 | 68 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 327 | 0.030 |
Why?
| | Genetic Testing | 1 | 2019 | 460 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1972 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 648 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2017 | 1079 | 0.020 |
Why?
| | Mice | 1 | 2008 | 17787 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2011 | 92 | 0.020 |
Why?
| | Transcription Factors | 1 | 2018 | 1719 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 318 | 0.020 |
Why?
| | Keratinocytes | 1 | 2011 | 249 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6079 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 594 | 0.020 |
Why?
| | Animals | 1 | 2008 | 36940 | 0.020 |
Why?
| | Signal Transduction | 1 | 2018 | 5079 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2011 | 1096 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4193 | 0.010 |
Why?
|
|
Siegele's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|